Cilian
M├╝nster
About Cilian
Cilian is an emerging biotechnology company developing and marketing a novel expression system. The Company uses a species of Ciliates, a eukaryotic single-cell organism, for the production of enzymes and therapeutic proteins. While Ciliates secrete a number of therapeutically relevant enzymes with high expression rates by nature, recombinant proteins are produced by Ciliates using genetically modified cells. Leveraging the unique capabilities of the Ciliates, the Company aims to produce proteins at an unmatched quality and price, thereby fulfilling its mission to improve human health by facilitating access to biopharmaceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.1M
- Funding stage: M&A
- Last round: Corporate Round (Oct 2009)
- Website: cilian.de
- Phone: +49 251 620 31-0
Industries & Categories
Biotechnology, Genetics, Life Science
Canonical: https://fsome.com/organization/cilian-2658009 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.